Group 1 - The company plans to use idle self-owned funds for cash management to improve fund utilization efficiency and increase returns for the company and its shareholders [4][9] - The total amount for cash management is set at a maximum of RMB 500 million, which can be used in a rolling manner within the specified limit [5][9] - The funds for this cash management will come from the company's idle self-owned funds and will not affect normal operations [6] Group 2 - The investment will focus on purchasing low-risk, high-liquidity financial products issued by banks and other financial institutions [7][10] - The investment period is valid for 12 months from the date of board approval [8][9] - The company will implement strict risk control measures, including selecting reputable investment targets and monitoring investment products [11][10] Group 3 - The cash management is expected to enhance the efficiency of fund usage and increase cash asset returns, benefiting both the company and its shareholders [13][70] - The company will adhere to relevant laws and regulations regarding information disclosure and fund management [12][63] - The cash management income will be prioritized for supplementing investment amounts for projects and daily operational liquidity [64]
百奥赛图（北京）医药科技股份有限公司 关于使用闲置自有资金进行现金管理的公告